These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The contractile activities of neurokinin A, B and related peptides on smooth muscles. Osakada F; Kubo K; Goto K; Kanazawa I; Munekata E Eur J Pharmacol; 1986 Jan; 120(2):201-8. PubMed ID: 2419146 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro actions of mammalian tachykinins. Holzer-Petsche U; Schimek E; Amann R; Lembeck F Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373 [TBL] [Abstract][Full Text] [Related]
5. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens. Hall JM; Morton IK Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714 [TBL] [Abstract][Full Text] [Related]
6. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity. Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378 [TBL] [Abstract][Full Text] [Related]
7. Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin. Laufer R; Wormser U; Friedman ZY; Gilon C; Chorev M; Selinger Z Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7444-8. PubMed ID: 2414777 [TBL] [Abstract][Full Text] [Related]
8. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity. Haro I; Busquets MA; Torres JL; Valencia G; Garcia-Anton JM; Reig F J Pharm Sci; 1990 Jan; 79(1):74-6. PubMed ID: 1690289 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles. Munekata E; Kubo K; Tanaka H; Osakada F Peptides; 1987; 8(1):169-73. PubMed ID: 2437548 [TBL] [Abstract][Full Text] [Related]
10. Highly selective agonists for substance P receptor subtypes. Wormser U; Laufer R; Hart Y; Chorev M; Gilon C; Selinger Z EMBO J; 1986 Nov; 5(11):2805-8. PubMed ID: 2431898 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological evidence for the possible coexistence of multiple receptor sites for mammalian tachykinins in rabbit iris sphincter smooth muscle. Hosoki R; Hisayama T; Takayanagi I Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):290-5. PubMed ID: 2438560 [TBL] [Abstract][Full Text] [Related]
13. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302 [TBL] [Abstract][Full Text] [Related]
14. Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile. Nawa H; Doteuchi M; Igano K; Inouye K; Nakanishi S Life Sci; 1984 Mar; 34(12):1153-60. PubMed ID: 6200746 [TBL] [Abstract][Full Text] [Related]
15. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907 [TBL] [Abstract][Full Text] [Related]
16. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype. Laufer R; Gilon C; Chorev M; Selinger Z J Med Chem; 1986 Jul; 29(7):1284-8. PubMed ID: 2433445 [TBL] [Abstract][Full Text] [Related]
17. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM; Flowers JM; Morton IK Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072 [TBL] [Abstract][Full Text] [Related]
18. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517 [TBL] [Abstract][Full Text] [Related]
19. Dimerization of neurokinin A and B COOH-terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes. Kodama H; Shimohigashi Y; Sakaguchi K; Waki M; Takano Y; Yamada A; Hatae Y; Kamiya H Eur J Pharmacol; 1988 Jul; 151(2):317-20. PubMed ID: 2844557 [TBL] [Abstract][Full Text] [Related]
20. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. Burcher E; Buck SH; Lovenberg W; O'Donohue TL J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]